Works matching IS 00178748 AND DT 2022 AND VI 62 AND IP 9
Results: 26
Erratum.
- Published in:
- 2022
- Publication type:
- Correction Notice
Headache and acute cerebrovascular disease: How do we differentiate primary and secondary headache disorders in the emergency setting?
- Published in:
- 2022
- Publication type:
- Editorial
Erratum.
- Published in:
- 2022
- Publication type:
- Correction Notice
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1143, doi. 10.1111/head.14400
- By:
- Publication type:
- Article
Off‐label use of lacosamide, an alternative for the treatment of neuropathic pain.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1239, doi. 10.1111/head.14399
- Publication type:
- Article
Headache as a COVID‐19 onset symptom and post‐COVID‐19 symptom in hospitalized COVID‐19 survivors infected with the Wuhan, Alpha, or Delta SARS‐CoV‐2 variants.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1148, doi. 10.1111/head.14398
- By:
- Publication type:
- Article
A non‐oral gepant for acute treatment of migraine.
- Published in:
- 2022
- Publication type:
- Editorial
The elephant in the room: How the underfunding of headache research stunts the field.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1234, doi. 10.1111/head.14396
- By:
- Publication type:
- Article
The teaching of headache medicine in France: A questionnaire‐based study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1177, doi. 10.1111/head.14395
- By:
- Publication type:
- Article
Headache persisting after aneurysmal subarachnoid hemorrhage: A narrative review of pathophysiology and therapeutic strategies.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1120, doi. 10.1111/head.14394
- By:
- Publication type:
- Article
Gestational exposure to erenumab—The outcome of three pregnancies.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1218, doi. 10.1111/head.14393
- By:
- Publication type:
- Article
Digital headache self‐management interventions for patients with a primary headache disorder: A systematic review of randomized controlled trials.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1105, doi. 10.1111/head.14392
- By:
- Publication type:
- Article
A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open‐label extension
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1207, doi. 10.1111/head.14391
- By:
- Publication type:
- Article
A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1164, doi. 10.1111/head.14390
- By:
- Publication type:
- Article
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1153, doi. 10.1111/head.14389
- By:
- Publication type:
- Article
A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene‐related peptide and beyond.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1093, doi. 10.1111/head.14388
- By:
- Publication type:
- Article
Short‐term stroke risk after emergency department treat‐and‐release headache visit.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1198, doi. 10.1111/head.14387
- By:
- Publication type:
- Article
A stated preference survey to explore patient preferences for novel preventive migraine treatments.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1187, doi. 10.1111/head.14386
- By:
- Publication type:
- Article
Narrative review of peripheral nerve blocks for the management of headache.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1077, doi. 10.1111/head.14385
- By:
- Publication type:
- Article
Dietary intake of thiamine and riboflavin in relation to severe headache or migraine: A cross‐sectional survey.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1133, doi. 10.1111/head.14384
- By:
- Publication type:
- Article
The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1231, doi. 10.1111/head.14383
- By:
- Publication type:
- Article
Essential but often overlooked reporting elements for Headache manuscripts.
- Published in:
- 2022
- Publication type:
- Editorial
Cluster headache – The worst possible pain on YouTube.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1222, doi. 10.1111/head.14368
- By:
- Publication type:
- Article
Lacosamide for refractory trigeminal neuralgia and other facial pain—Case report.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1227, doi. 10.1111/head.14367
- Publication type:
- Article
B1 and/or B2? That is the question.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1071, doi. 10.1111/head.14338
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1, doi. 10.1111/head.14163
- Publication type:
- Article